Breo Ellipta vs Advair Diskus
A side-by-side look at two respiratory medications advertised on TV. Informational only — not medical advice.
| US Breo Ellipta | US Advair Diskus | |
|---|---|---|
| Generic name | fluticasone/vilanterol | fluticasone/salmeterol |
| Drug class | ICS/LABA Inhaler | Inhaled Corticosteroid / LABA Combination |
| Treats | Asthma, COPD | Asthma and COPD |
| Category | Respiratory | Respiratory |
| Manufacturer | GSK | GSK |
| Year approved | 2013 | 2000 |
| FDA warning | No boxed warning | Moderate warnings |
| Est. TV ad spend | $100M | — |
| Common side effects | Oral thrush, Throat irritation, Headache, Common cold symptoms | Thrush (mouth infection), Hoarse voice, Headache, Throat irritation |
Breo Ellipta
Advair Diskus
Frequently asked questions
Is Breo Ellipta or Advair Diskus better?
Neither is universally "better." Breo Ellipta (fluticasone/vilanterol) and Advair Diskus (fluticasone/salmeterol) are both used for respiratory, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Breo Ellipta and Advair Diskus?
Breo Ellipta is a ICS/LABA Inhaler made by GSK, while Advair Diskus is a Inhaled Corticosteroid / LABA Combination made by GSK. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Breo Ellipta has the larger estimated TV advertising budget of the two.